CLINICAL TRIALS
Biomobie Technology
[The Efficacy of BioBoosti 8 Minute Electromagnetic Cycles for the Treatment of Insomnia]

Medical Breakthrough with Biomobie Partner Harvard University

 

A study at Harvard University revealed that those 30-35% of the American population suffering insomnia now have a non-pharmaceutical option. Biomobie’s non-pharmaceutical, non-invasive, precision technology device has been demonstrated to relieve insomnia using revolutionary bioelectricity according to clinical trials conducted by Harvard University.

 

Massive Insomnia Problem and Health Risk

In February, 2016, the Centers for Disease Control and Prevention (CDC) published a press release notifying the public that fully 1 out of every 3 adults in the United States reported obtaining less than the recommended seven hours of nightly sleep on a regular basis. During the course of a given year, up to 40% of the adult population in the United States reports experiencing insomnia, with 60% of the people reporting insomnia suffering from some type of chronic health disorder. Over half of Americans aged 65 or older reported sleeping less than seven hours a night.

 

The World Health Organization studied insomnia (2004) and reported that insomnia has been statistically associated with various medical conditions, including disorders of the cardiovascular, respiratory, gastrointestinal, renal and musculoskeletal systems. A large study of insomniacs showed that poor sleepers are more than twice as much at risk of ischemic heart disease as good sleepers. Most individuals develop cognitive deficits from chronic sleep debt after only a few nights of reduced sleep quality or quantity; new evidence suggests additional important health-related consequences of sleep debt related to common viral illnesses, diabetes, obesity, heart disease, depression and other age-related chronic disorders.

哈佛大学治疗失眠临床医学研究取得重大突破

 

哈佛大学临床试验证明,百慕迪发明的一种非药物,非侵入性,创新性的生物电技术能有效缓解失眠症状。为占美国总人口 30-35%的失眠症患者提供了一种新的非药物治疗手段。这一结果远远高于治疗失眠的传统药物有效性。目前哈佛大学仍在继续研究扩大临床试验人群并启动了偏头痛的临床试验。

 

大规模的失眠问题与健康风险

2016 年 2 月,美国疾病控制和预防中心(CDC)发布的一篇新闻稿称,美国三分之一的成年人睡眠时间不足 7 小时。在某些年份内,失眠患者的比例甚至可高达 40%,其中 60%的失眠患者伴有慢性疾病。65 岁及以上的美国人中有超过一半睡眠时间少于 7 小时。

世界卫生组织研究报告(2004 年)称,失眠问题与多种疾病具有统计学相关性,包括心血管疾病,呼吸系统疾病,胃肠疾病,肾脏疾病和肌肉骨骼系统疾病。一项关于失眠症的大型研究表明,睡眠欠佳的人患缺血性心脏病的风险是睡眠良好者的 2 倍以上。大多数人即使仅仅几天的睡眠质量或睡眠时长下降,也会引起注意力、学习力、记忆力等下降;新的研究证据表明睡眠障碍会导致其他很多重要健康问题,如病毒性疾病、糖尿病、肥胖症、心脏病、抑郁症和其他与年龄相关的慢性疾病等。

Harvard University
brigham & Women’S Hospital
John R. Graham Headache Center
Biomobie 全部产品细节都已经过国家专利版权保护
未经授权不得以任何方式盗用或模仿
违者必究
Biomobie all product details have been over the nationanl patent copyright protection Without authorization
shall not be used in any way to steal or imitate
Those who violate the law will be subject to legal sanctions

Biomobie (shanghai) Regenerative Medicine co., Ltd.

扫描二维码分享到微信